When and How to Evaluate the Natural Killer Cell Function

References (252)

1. 1 Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome [DOI]
2. 2 Cheese: Chemistry, Physics and Microbiology [DOI]
3. 3 A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity [DOI]
4. 4 The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. [DOI]
5. 5 Interleukin-2 augments natural killer cell activity [DOI]
6. 6 NK cells and cancer immunosurveillance [DOI]
7. 7 Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians [see comments] [DOI]
8. 8 Selective Enumeration of Lactobacillus delbrueckii ssp. bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacteria, Lactobacillus casei, Lactobacillus rhamnosus, and Propionibacteria [DOI]
9. 9 Mechanisms of action of CD20 antibodies.
10. 10 Cytotoxic immunological synapses [DOI]
11. 11 Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells [DOI]
12. 12 Inherited defects in lymphocyte cytotoxic activity [DOI]
13. 13 Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.
14. 14 Low natural killer‐cell activity and immunoglobulin levels associated with smoking in human subjects [DOI]
15. 15 Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15 [DOI]
16. 16 Natural Killer Cells in the Late Decades of Human Life [DOI]
17. 17 Europium-labelled target cells in an assay of natural killer cell activity [DOI]
18. 18 Probiotics 2 : applications and practical aspects
19. 19 Application of Membrane Separation Technology to Cheese Production [DOI]
20. 20 Production of Probiotic Cheese (Cheddar-Like Cheese) Using Enriched Cream Fermented by Bifidobacterium infantis [DOI]
21. 21 Circadian Rhythms of Granzyme B, Perforin, IFN-γ, and NK Cell Cytolytic Activity in the Spleen: Effects of Chronic Ethanol [DOI]
22. 22 Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen is Associated with Elevated IL-15 Levels [DOI]
23. 23 The Use of the MTT Assay to Study Drug Resistance in Fresh Tumour Samples [DOI]
24. 24 A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis [DOI]
25. 25 Comprehensive analysis of NK cell function in whole blood samples [DOI]
26. 26 A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry [DOI]
27. 27 Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians [DOI]
28. 28 Manufacture of cheese from milk concentrated by ultrafiltration [DOI]
29. 29 Numerical and Functional Characteristics of Lymphocyte Subsets in Centenarians [DOI]
30. 30 Europium-labelled target cells in an assay of natural killer cell activity [DOI]
31. 31 Identification and Characterization of a Transmembrane Isoform of CD160 (CD160-TM), a Unique Activating Receptor Selectively Expressed upon Human NK Cell Activation [DOI]
32. 32 Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity [DOI]
33. 33 A Selective Enumeration Medium for Bifidobacteria in Fermented Dairy Products [DOI]
34. 34 Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections [DOI]
35. 35 Genetic Modification of Natural Killer Cells For Adoptive Cellular Immunotherapy [DOI]
36. 36 Nonsecretory apoptotic killing by human NK cells [DOI]
37. 37 Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells [DOI]
38. 38 MEDIA SELECTION FOR POLY(HYDROXYBUTYRATE) PRODUCTION FROM METHANOL BY METHYLOBACTERIUM EXTORQUENS DSMZ 1340 [DOI]
39. 39 Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. [DOI]
40. 40 Natural killer function in flow cytometry [DOI]
41. 41 Cytolytic activity of human natural killer cell subpopulations isolated by four‐color immunofluorescence flow cytometric cell sorting [DOI]
42. 42 Natural killer function in flow cytometry [DOI]
43. 43 ORIGINAL ARTICLE: Suppression of Natural Killer Cell Cytotoxicity in Postpartum Women [DOI]
44. 44 Flow Cytometry–Based Cytotoxicity and Antibody Binding Assay [DOI]
45. 45 Development of immunomonitoring of antibody-dependent cellular cytotoxicity against neuroblastoma cells using whole blood [DOI]
46. 46 Natural killer function in flow cytometry [DOI]
47. 47 A highly sensitive whole blood natural killer cell assay [DOI]
48. 48 Signal Transduction During Natural Killer Cell Activation [DOI]
49. 49 Assays of Natural Killer ( NK ) Cell Ligation to Target Cells [DOI]
50. 50 Ultrafiltration and Microfiltration Handbook [DOI]
51. 51 In search of the ‘missing self’: MHC molecules and NK cell recognition [DOI]
52. 52 CD107a as a functional marker for the identification of natural killer cell activity [DOI]
53. 53 Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics [DOI]
54. 54 Human natural killer cell development and biology [DOI]
55. 55 Relationship between CD107a expression and cytotoxic activity [DOI]
56. 56 Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells [DOI]
57. 57 Natural killer cells in human health and disease [DOI]
58. 58 Probiotic cheese: Health benefits, technological and stability aspects [DOI]
59. 59 Natural killer cell cytotoxicity: how do they pull the trigger? [DOI]
60. 60 Physical and Functional Association of LFA-1 with DNAM-1 Adhesion Molecule [DOI]
61. 61 Viability of Probiotic (Bifidobacterium, Lactobacillus acidophilus and Lactobacillus casei) and Nonprobiotic Microflora in Argentinian Fresco Cheese [DOI]
62. 62 Molecular and cellular pathogenesis of X‐linked lymphoproliferative disease [DOI]
63. 63 LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity [DOI]
64. 64 Effects of Chlorella vulgaris and Arthrospira platensis addition on viability of probiotic bacteria in yogurt and its biochemical properties [DOI]
65. 65 Probiotic white cheese with Lactobacillus acidophilus [DOI]
66. 66 Clinical Cancer Therapy by NK Cells via Antibody‐Dependent Cell‐Mediated Cytotoxicity [DOI]
67. 67 Expression and regulation of chemokine receptors in human natural killer cells [DOI]
68. 68 Modulation of Nonspecific Mechanisms of Defense by Lactic Acid Bacteria: Effective Dose [DOI]
69. 69 A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity [DOI]
70. 70 A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: Comparisons to a 4 h 51Cr-release assay [DOI]
71. 71 Comparative Studies on Synthesis of Water-soluble Vitamins among Human Species of Bifidobacteria [DOI]
72. 72 Cell adhesion and polarity during immune interactions [DOI]
73. 73 Decreased natural killer cell activity is associated with atherosclerosis in elderly humans [DOI]
74. 74 Changes in the rheological properties of Iranian UF-Feta cheese during ripening [DOI]
75. 75 Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF- β 1) in Patients with Gastric Cancer [DOI]
76. 76 IL-21 augments natural killer effector functions in chronically HIV-infected individuals [DOI]
77. 77 Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays [DOI]
78. 78 Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia [DOI]
79. 79 Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity [DOI]
80. 80 Rapid flow cytometric assay for the assessment of natural killer cell activity [DOI]
81. 81 An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity [DOI]
82. 82 Low natural killer activity and central nervous system disease as a high‐risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosis [DOI]
83. 83 Increased Natural Killer Cell Cytotoxicity and IL‐2 Production in Recurrent Spontaneous Abortion [DOI]
84. 84 A novel enhanced green fluorescent protein (EGFP)-K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity [DOI]
85. 85 A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells [DOI]
86. 86 Immunological Effects of Interferon-alpha on Chronic Myelogenous Leukemia [DOI]
87. 87 A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells [DOI]
88. 88 Natural Killer Cell Cytotoxicity: A Methods Analysis of Versus Flow Cytometry Chromium Release [DOI]
89. 89 Implementation of the EGFP‐K562 flow cytometric NK test: Determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding [DOI]
90. 90 VIABILITY OF BIFIDOBACTERIUM LA CTIS AND LACTOBACILL US ACIDOPHILUS IN MILK: SODIUM CHLORIDE CONCENTRATION AND STORAGE TEMPERATURE [DOI]
91. 91 NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome [DOI]
92. 92 Low Natural Killer Cell Function in Disseminated Aspergillosis [DOI]
93. 93 Modified procedure for labelling target cells in a europium release assay of natural killer cell activity [DOI]
94. 94 Lonely killers [DOI]
95. 95 Intracellular determination of activated caspases (IDAC) by flow cytometry using a pancaspase inhibitor labeled with FITC [DOI]
96. 96 Quantitation and sorting of vitally stained natural killer cell‐target cell conjugates by dual beam flow cytometry [DOI]
97. 97 Effect of conjugate size on the kinetics of cell-mediated cytotoxicity at the population level [DOI]
98. 98 NATURAL KILLER CELL ACTIVITY AND ANTIBODY‐DEPENDENT CELLULAR CYTOTOXICITY IN NEWBORN INFANTS [DOI]
99. 99 Natural Killer Cell Activity in Early Human Pregnancy [DOI]
100. 100 Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method [DOI]
101. 101 Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. [DOI]
102. 102 Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3) [DOI]
103. 103 The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity [DOI]
104. 104 Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants [DOI]
105. 105 CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells [DOI]
106. 106 Evaluation of Media for Selective Enumeration of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and Bifidobacteria [DOI]
107. 107 A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes [DOI]
108. 108 Wiskott–Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses [DOI]
109. 109 An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry [DOI]
110. 110 Interactions Among Lactic Acid Starter and Probiotic Bacteria Used for Fermented Dairy Products [DOI]
111. 111 Human natural killer cell deficiencies [DOI]
112. 112 Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients [DOI]
113. 113 Development of Probiotic Cheese Manufactured from Goat Milk: Response Surface Analysis via Technological Manipulation [DOI]
114. 114 Spectrum of Perforin Gene Mutations in Familial Hemophagocytic Lymphohistiocytosis [DOI]
115. 115 Partial albinism with immunodeficiency (Griscelli syndrome) [DOI]
116. 116 Media for the isolation and enumeration of bifidobacteria in dairy products [DOI]
117. 117 Appraisal of the MTT-based Assay as a Useful Tool for Predicting Drug Chemosensitivity in Leukemia [DOI]
118. 118 Natural killer cells: integrating diversity with function [DOI]
119. 119 The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells [DOI]
120. 120 Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species [DOI]
121. 121 Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function [DOI]
122. 122 Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies [DOI]
123. 123 Natural killer cell engineering for cellular therapy of cancer [DOI]
124. 124 Cell Transfer Therapy for Cancer: Past, Present, and Future [DOI]
125. 125 Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia [DOI]
126. 126 Effects of Aging on Natural Killer Cell Activity and Activation by Interleukin-2 and IFN-α [DOI]
127. 127 Flow cytometric analysis of natural killer cell function as a clinical assay [DOI]
128. 128 A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry [DOI]
129. 129 Measurement of CTL-induced cytotoxicity: The caspase 3 assay [DOI]
130. 130 A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells [DOI]
131. 131 Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay [DOI]
132. 132 A very sensitive coupled luminescent assay for cytotoxicity and complement-mediated lysis [DOI]
133. 133 Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis [DOI]
134. 134 NK-cell activity in immunotoxicity drug evaluation [DOI]
135. 135 Regulation of Anti-HLA Antibody-Dependent Natural Killer Cell Activation by Immunosuppressive Agents [DOI]
136. 136 Interleukin-2 (IL-2) augments host cellular immune reactivity in the perioperative period in patients with malignant disease [DOI]
137. 137 Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells [DOI]
138. 138 NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method [DOI]
139. 139 Toward the next generation of NK cell-based adoptive cancer immunotherapy [DOI]
140. 140 A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity [DOI]
141. 141 Cell‐mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere‐adjusted counts on three‐color flow cytometry [DOI]
142. 142 Kinetics of in vitro natural killer activity against K562 cells as detected by flow cytometry [DOI]
143. 143 Natural Killer Cells: Tolerance to Self and Innate Immunity to Viral Infection and Malignancy [DOI]
144. 144 Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay [DOI]
145. 145 A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells [DOI]
146. 146 Measuring T cell-mediated cytotoxicity using fluorogenic caspase substrates [DOI]
147. 147 Immunosenescence of human NK cells: effects on tumor target recognition, lethal hit and interferon sensitivity [DOI]
148. 148 Responses of natural killer cell activity to acute laboratory stressors in healthy men at different times of day. [DOI]
149. 149 Improving methods of assessing natural killer cell cytotoxicity [DOI]
150. 150 Flow cytometry evaluation of cell-mediated cytotoxicity [DOI]
151. 151 An enzyme-release assay for natural cytotoxicity [DOI]
152. 152 Technological challenges for future probiotic foods [DOI]
153. 153 Unravelling natural killer cell function: triggering and inhibitory human NK receptors [DOI]
154. 154 Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections [DOI]
155. 155 Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients [DOI]
156. 156 Calcein-Acetyoxymethyl Cytotoxicity Assay: Standardization of a Method Allowing Additional Analyses on Recovered Effector Cells and Supernatants [DOI]
157. 157 Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma [DOI]
158. 158 Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity [DOI]
159. 159 Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors [DOI]
160. 160 NKG2D ligands as therapeutic targets.
161. 161 Evidence for NK Cell Subsets Based on Chemokine Receptor Expression [DOI]
162. 162 Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy [DOI]
163. 163 Clinical utility of natural killer cells in cancer therapy and transplantation [DOI]
164. 164 Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage [DOI]
165. 165 Engineering lymph node homing of ex vivo–expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7 [DOI]
166. 166 Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26 [DOI]
167. 167 Natural killer cells in the treatment of high-risk acute leukaemia [DOI]
168. 168 Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. [DOI]
169. 169 Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged ≥90 y [DOI]
170. 170 Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology [DOI]
171. 171 Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell–induced apoptosis [DOI]
172. 172 The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity [DOI]
173. 173 Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) [DOI]
174. 174 Hemophagocytic lymphohistiocytosis and related disorders [DOI]
175. 175 Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke [DOI]
176. 176 Detection of dead cells and measurement of cell killing by flow cytometry [DOI]
177. 177 Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients [DOI]
178. 178 Human Natural Killer Receptors, Co‐Receptors, and Their Ligands [DOI]
179. 179 Determination of natural killer cell function by flow cytometry [DOI]
180. 180 Characterization of peripheral natural killer cells in primary Sjögren’s syndrome: Impaired NK cell activity and low NK cell number [DOI]
181. 181 Immunophenotypic Characterization of Normal Blood CD56+lo Versus CD56+hi NK-Cell Subsets and Its Impact on the Understanding of Their Tissue Distribution and Functional Properties [DOI]
182. 182 Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies [DOI]
183. 183 Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity [DOI]
184. 184 A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. [DOI]
185. 185 Development of structure and texture in Cheddar cheese [DOI]
186. 186 Natural Killer (NK) Cell Subsets and NK Cell Cytotoxicity in Women with Histories of Recurrent Spontaneous Abortions [DOI]
187. 187 Distribution and lytic activity of NK cell subsets in the elderly [DOI]
188. 188 APPLICATION OF PLACKETT BURMAN DESIGN FOR CITRIC ACID PRODUCTION FROM PRETREATED AND UNTREATED WHEAT STRAW [DOI]
189. 189 Production of propionic acid in a fermented dairy beverage [DOI]
190. 190 Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level [DOI]
191. 191 A novel immunomodulatory mechanism of ribavirin in suppressing natural killer cell function [DOI]
192. 192 Chediak-Higashi gene in humans. II. The selectivity of the defect in natural- killer and antibody-dependent cell-mediated cytotoxicity function [DOI]
193. 193 An improved double fluorescence flow cytometry method for the quantification of killer cell/target cell conjugate formation [DOI]
194. 194 An improved assay for antibody dependent cellular cytotoxicity based on time resolved fluorometry [DOI]
195. 195 Reactive phenotypes after acute and chronic NK-cell activation.
196. 196 Natural killer function in flow cytometry: Identification of human lymphoid subsets able to bind to the NK sensitive target K562 [DOI]
197. 197 Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay [DOI]
198. 198 A GFP-Transfected HFWT Cell Line, GHINK-1, as a Novel Target for Non-RI Activated Natural Killer Cytotoxicity Assay [DOI]
199. 199 Monoclonal Antibodies for the Immunotherapy of Solid Tumours [DOI]
200. 200 Target lysis by human lak cells is critically dependent upon target binding properties, but LFA‐1, LFA‐3 AND ICAM‐1 are not the major adhesion ligands on targets [DOI]
201. 201 HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [DOI]
202. 202 Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants [DOI]
203. 203 Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [DOI]
204. 204 Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis [DOI]
205. 205 Functional cultures and health benefits [DOI]
206. 206 NK cell-based immunotherapy for malignant diseases [DOI]
207. 207 Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression [DOI]
208. 208 NK Cells and Cancer [DOI]
209. 209 The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression [DOI]
210. 210 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells [DOI]
211. 211 Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma [DOI]
212. 212 Viral infections associated with haemophagocytic syndrome [DOI]
213. 213 Natural Killer Cells in Obesity: Impaired Function and Increased Susceptibility to the Effects of Cigarette Smoke [DOI]
214. 214 Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning [DOI]
215. 215 Bringing natural killer cells to the clinic: ex vivo manipulation [DOI]
216. 216 Advantages and clinical applications of natural killer cells in cancer immunotherapy [DOI]
217. 217 Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome [DOI]
218. 218 Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations [DOI]
219. 219 Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions [DOI]
220. 220 Production of Cottage Cheese Using Dressing Fermented by Bifidobaceria [DOI]
221. 221 Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.
222. 222 Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency.Defects of the gc‐JAK3 signaling pathway as a model [DOI]
223. 223 The battlefield of perforin/granzyme cell death pathways [DOI]
224. 224 At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies [DOI]
225. 225 Chediak-Higashi gene in humans. I. Impairment of natural - killer function [DOI]
226. 226 Increased Natural Killer-Cell Mobilization and Cytotoxicity during Marital Conflict [DOI]
227. 227 Evaluation of probiotic survivability in yogurt exposed to cold chain interruption.
228. 228 Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma [DOI]
229. 229 The “ex Vivo” Patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR Expression Identify Acute/Early and Chronic/Late NK-Cell Activation States [DOI]
230. 230 Oral supplementation with lactic acid-producing bacteria during intake of clindamycin [DOI]
231. 231 Evaluation of cytotoxic function and apoptosis in interleukin (IL)‐12/IL‐15‐treated umbilical cord or adult peripheral blood natural killer cells by a propidium‐iodide based flow cytometry [DOI]
232. 232 An Experimental Design for Production of Selenium-Enriched Yeast
233. 233 NK Cell Receptors and Their Interactions with MHC [DOI]
234. 234 Modulation of natural killer cell effector functions through lenalidomide/dasatinib and their combined effects against multiple myeloma cells [DOI]
235. 235 NK Cell Assays in Immunotoxicity Testing [DOI]
236. 236 Quantitative Fluorescence Measures for Determination of Intracellular Perforin Content [DOI]
237. 237 A differential assay of NK-cell-mediated cytotoxicity in K562 cells revealing three sequential membrane impairment steps using three-color flow-cytometry [DOI]
238. 238 Natural Killer Cell Function in Patients With Acquired Immunodeficiency Syndrome and Related Diseases [DOI]
239. 239 Cytotoxic reactivity of human natural killer (NK) cells during normal pregnancy: a longitudinal study.
240. 240 Heterogeneity of Immune Markers in Hemophagocytic Lymphohistiocytosis [DOI]
241. 241 Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity [DOI]
242. 242 Interleukin-2 and natural killer activity in acute type B hepatitis.
243. 243 Functional NK Cell Cytotoxicity Assays Against Virus Infected Cells [DOI]
244. 244 Methods to Identify and Characterize Different NK Cell Receptors and Their Ligands [DOI]
245. 245 [Selective defect on interferon secretion associated with impaired natural killing activity (author's transl)].
246. 246 Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates. [DOI]
247. 247 Clinical Analysis of Human Natural Killer Cells [DOI]
248. 248 The over-expression of P-glycoprotein in K-562 and DAUDI cells, is associated with a high susceptibility to NK and LAK cells.
249. 249 Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
250. 250 Hemophagocytic lymphohistiocytosis: a lethal disorder of immune regulation.
251. 251 Functional Analysis of Human NK Cells by Flow Cytometry [DOI]
252. 252 Feta and Related Cheeses [DOI]

Cited by 4

Showing 1 of 4 known citations — external sources report more than can currently be individually listed.

Related research

• In vivo Cell Tracking and Signalling with Various Imaging Modalities — shares topic coverage
• Newly Exposed Membrane Glycoprotein II β (CD41) on Activated Platelets has Higher Affinity for Plasma Fibrinogen that Blocks Anti-CD41 Binding — shares topic coverage
• Advances in the Diagnosis of Chronic Lymphoid Neoplasms in Côte d'Ivoire: Toward Improvement — shares topic coverage
• Effect of 67Zn-Nanoparticles on Leukemic Cells and Normal Lymphocytes — shares topic coverage
• Genome Status of Lippia alba Polyploid Complex Long-term in vitro Cultivated — shares topic coverage